BNTC SG&A Expense Growth
Benitec Biopharma Inc · SG&A Expense Growth
BNTC SG&A Expense Growth
Latest reported18.65%period ending
BNTC FY SG&A Growth (YoY) (0.00% → 18.65%)
Latest values, visible window
High-resolution chart · PNG
BNTC sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 18.6532% | |
| 235.284% | |
| 9.5111% | |
| -3.9723% | |
| 2.0577% | |
| 16.975% | |
| 72.5996% | |
| -31.6413% | |
| -11.8166% | |
| -17.9971% | |
| 39.0538% | |
| -34.8437% | |
| 77.6734% | |
| 85.8287% | |
| 164.8189% | |
| -44.2537% | |
| -7.7406% | |
| -33.3427% | |
| 98.9839% | |
| -42.1992% | |
| -81.0397% | |
| 60.2201% | |
| 0% |